FRANCES THOM: Open Payments
NPI 1730369356 · NICHOLASVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 16 payments from 10 companies in 2025. Trend: 2023 $223 · 2024 $307 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $62 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| Lundbeck LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Auvelity, Qelbree, REXULTI, FANAPT, VRAYLAR, INGREZZA, Jornay PM, BREZTRI.
Industry payments across KY — which companies pay providers there.
